top of page
ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome
Top
Stay Connected
Follow us on social media
Events
Newsroom
Contact Us
bottom of page
